| Literature DB >> 24467833 |
Khalil Zro, Fathiah Zakham, Marouane Melloul, Elmostafa El Fahime, Moulay Mustapha Ennaji1.
Abstract
BACKGROUND: Sheeppoxvirus (SPPV) is a member of the Capripoxvirus genus of the Poxviridae family, which causes significant economic losses in Morocco. The resurgence of the sheeppox disease during 2010 was characterized by an emergence of a classical nodular form for the first time in Morocco. However, little is known about the virus strain responsible for nodular form. In this study, thirty three sheep, from the eastern region of Morocco, clinically infected were examined and dead animals were autopsied.A rapid diagnostic assay for SPPV using different type of clinical samples would be useful for outbreak management. The aim of this work was to isolate the virus strain responsible for nodular form and we identified and compared by phylogenetic analysis the field strain with Moroccan vaccine strain targeting the thymidine kinase (TK) gene and the chemokine analogue receptor of interleukin (IL8) gene. Further, it was important to investigate and validate a real-time PCR using different clinical and post-mortem samples to manage epidemic sheeppox disease.Entities:
Mesh:
Year: 2014 PMID: 24467833 PMCID: PMC3922166 DOI: 10.1186/1746-6148-10-31
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Figure 1Characteristic symptoms of the new clinical form of sheep pox disease in Morocco. (A) Typical nodules lesion in internal face of the thigh of the lamb; (B) nodule lesions like tumor skin on the teat and udder affected with sheep pox virus; (C) Typical pox lesions observed on the lungs and liver of a lamb; (D) Acute inflammatory reaction associated with hyperplasia of the skin caused by wild strain SPPV.
Results (threshold cycle values) of real-time PCR obtained from suspected clinical samples
| | ||||||
|---|---|---|---|---|---|---|
| 1 (outbreak n° 1) | 25,93 | 25,97 | 30,83 | 36,2 | 19,88 | - |
| 2 (outbreak n° 1) | 27,57 | 27,8 | 32,77 | 38 | 22,88 | - |
| 3 (outbreak n° 1) | 29,12 | 31,08 | 28,32 | 37,6 | - | - |
| 4 (outbreak n° 1) | 30,28 | 30,83 | 40,03 | 30,75 | - | - |
| 5 (outbreak n° 1) | 31,97 | 32,8 | 35 | 39,87 | 19,59 | - |
| 6 (outbreak n° 1) | 38,33 | 26,07 | 38,93 | 37,78 | - | - |
| 7 (outbreak n° 1) | 25,82 | 39,75 | 33,6 | 33,42 | - | - |
| 8 (outbreak n° 1) | No Ct | 42,5 | No Ct | - | - | 18,7 |
| 9 (outbreak n° 1) | 39,93 | No Ct | 39,21 | 37,1 | - | - |
| 10 (outbreak n° 1) | 38,3 | 22,97 | 30,32 | 37,8 | - | - |
| 11 (outbreak n° 1) | 24,03 | 24,5 | 37,17 | 40,93 | 20,98 | - |
| 12 (outbreak n° 1) | 21,56 | 35,95 | No Ct | - | - | 17,95 |
| 13 (outbreak n° 2) | 35,07 | 33,25 | 38,78 | 41,1 | - | - |
| 14 (outbreak n° 2) | 29,8 | 28,83 | No Ct | 36,5 | - | - |
| 15 (outbreak n° 2) | 30,69 | 34,64 | 42,5 | 30,29 | - | - |
| 16 (outbreak n° 3) | 36,64 | 31,21 | 35,6 | No Ct | - | - |
| 17 (outbreak n° 3) | 34 | 29,86 | 36,04 | No Ct | - | - |
| 18 (outbreak n° 3) | 29,7 | 33,5 | 38,75 | - | - | 19,93 |
| 19 (outbreak n° 3) | 34,2 | 33,93 | 34,93 | 40,75 | - | - |
| 20 (outbreak n° 3) | 33,92 | 36,33 | 38,2 | 36,4 | - | |
| 21 (outbreak n° 4) | 35,07 | 37,9 | 39,5 | 33,96 | - | |
| 22 (outbreak n° 4) | 40,48 | 40,16 | 41,1 | - | - | 20,37 |
| 23 (outbreak n° 4) | 41,7 | 35,87 | 35,1 | No Ct | - | - |
| 24 (outbreak n° 4) | 40,16 | 35,83 | 34,83 | 38,04 | - | - |
| 25 (outbreak n° 4) | 35,66 | 33,3 | 39,5 | 35,86 | - | - |
| 26 (outbreak n° 5) | No Ct | 33,95 | 35,32 | No Ct | - | - |
| 27 (outbreak n° 5) | 37,5 | 31,39 | 40,3 | 40,68 | - | - |
| 28 (outbreak n° 5) | 33,96 | 30,42 | 39,5 | - | - | 22,94 |
| 29 (outbreak n° 6) | 27,5 | 27,5 | 38 | No Ct | - | - |
| 30 (outbreak n° 6) | 40 | 27,18 | 39,5 | 40,67 | - | - |
| 31 (outbreak n° 6) | 24,58 | 22,28 | 38 | No Ct | - | - |
| 32 (outbreak n° 6) | 19,39 | 26,8 | 29,89 | 39,48 | - | - |
| 33 (outbreak n° 7) | 28,79 | 22 | 26,62 | 33,84 | - | - |
-° : sampling unrealized.
The sensitivity of the PCR on different clinical samples
| Sensitivity of PCR (%) | 96,97 (32/33) | 93,94 (31/33) | 90,91 (30/33) | 66,67 (22/28) | 100 (4/4) | 100 (5/5) |
Figure 2Specific amplification of the TK gene by two pairs of primers and receptor gene analogous to IL8 by a single primer pair. 1: vaccine Romania 65 strain. 2: isolate field strain. MW: Molecular Wight.
Figure 3Phylogenetic tree of TK. Strains of SPPV species are shown in a separated outlier and strain of interest is clustering with the vaccine Romani 65 strain (Moroccan vaccine).
Figure 4Phylogenetic tree of receptor gene analogous to IL8. Strains of SPPV species are clustering together, while Romania 65 is presented by a separated clade.